Uncategorized
Simbrinza approved in EU for treatment of glaucoma
The European Commission has approved brinzolamide and brimonidine tartrate eye drops suspension for the treatment of elevated IOP in adults with open-angle glaucoma or ocular hypertension, according to a press release.Brinzolamide 10 mg/mL and brimonidine tartrate 2 mg/mL (Simbrinza, Alcon/Novartis) is indicated for one drop into the affected eye(s) twice daily, allowing for a simpler schedule compared with separate doses of brinzolamide and brimonidine.